Increasing Sensitivity and Selectivity in Biotherapeutic Quantitative Analysis
Bimatoprost is a synthetic compound used in the treatment of glaucoma and other eye conditions. It is prescribed at low dosages and often achieves maximum plasma concentration in under 10 minutes. Hence, sensitive bioanalytical methods are essential to quantify bimatoprost in biological matrices to support pharmacokinetic studies.
This application note presents a reliable and highly sensitive workflow to support routine quantitative analysis in biotherapeutics such as bimatoprost that require low-level quantitation.
Download this application note to discover:
- A system with increased MS/MS sampling compared to other methods
- Highly reproducible quantitative performance at all concentration levels
- An integrated software solution for compliance-ready data management